IN VITRO DIAGNOSTICS Mergers & Acquisitions Roche Roche Professional Diagnostics Dynabyte Informationssysteme GMBH Verum Diagnostica GMBH Roche Professional Diagnostics (RPD; part of Roche) is p
The private US biotechnology company Signum Biosciences has appointed Dr Braham Shroot, formerly chief scientific officer of Barrier Therapeutics, as CEO. Dr Shroot succeeds Dr Gregory Stock, who will